FOR IMMEDIATE RELEASE | March 26, 2018
American Chemical Society applauds FY 2018 omnibus spending package
WASHINGTON, March 26, 2018 — The American Chemical Society (ACS) welcomes the bipartisan cooperation that occurred in completing the fiscal 2018 (FY 2018) omnibus appropriations act. The measure provides funding for scientific research and for science, technology, engineering and mathematics (STEM) education programs at federal agencies such as the Department of Energy’s Office of Science, the National Institute of Standards and Technology, the National Institutes of Health and the National Science Foundation.
“ACS continues to encourage congressional leadership and the Trump administration to work together to provide strong, robust and predictable funding levels for scientific research and STEM education,” says Glenn S. Ruskin, director of External Affairs & Communications at ACS. “Investments in these areas are important, as science and education are key elements of the U.S. innovation pipeline that drives job creation and economic growth.”
The FY 2018 omnibus spending package retains funding for programs such as the U.S. Chemical Safety & Hazard Investigation Board and the Department of Energy’s Advanced Research Projects Agency – Energy. For education, the spending bill retains funding for Title II Teacher Quality State Grants and provides an increase for Title IV, Student Support and Academic Achievement State Grants, which house many critical STEM education programs at the Department of Education. Further, ACS supports report language calling on the National Science Foundation to establish plans for a long-term sustainable chemistry program.
The American Chemical Society, the world’s largest scientific society, is a not-for-profit organization chartered by the U.S. Congress. ACS is a global leader in providing access to chemistry-related information and research through its multiple databases, peer-reviewed journals and scientific conferences. ACS does not conduct research, but publishes and publicizes peer-reviewed scientific studies. Its main offices are in Washington, D.C., and Columbus, Ohio.